CVS Lawsuit: Prescription Copay Overcharges
Discover how CVS allegedly overcharges insured patients for generics, making cash prices cheaper—and what you can do to fight back and save.
A groundbreaking class-action lawsuit accuses CVS of overcharging insured patients for generic prescription drugs, with copays often exceeding cash prices. Named plaintiff Megan Schultz paid $165 through insurance for a medication that cost just $92 in cash, highlighting a scheme allegedly funneling excess payments to pharmacy benefit managers (PBMs).
This practice, affecting millions, raises serious questions about pharmacy pricing transparency. Patients believe they’re saving with insurance, but lawsuits claim they’re paying more. Understanding this could help you slash drug costs immediately.
What the CVS Copay Lawsuit Alleges
The 51-page federal lawsuit, filed in California, contends CVS inflates copays for insured customers on certain generics, then rebates portions to PBMs like CVS Caremark. These ‘kickbacks’ create incentives for higher charges, harming consumers who pay more than cash buyers.
Copays are presented as insurance plan terms, but pharmacies control billing. The suit argues confidential pharmacy-PBM deals prioritize profits over patient savings, violating consumer protection laws.
- Key Allegation: Insured copays exceed ‘usual and customary’ (U&C) cash prices CVS offers publicly.
- Mechanism: CVS bills insurers/PBMs inflated amounts, retaining spreads while patients overpay copays.
- Impact: Consumers forfeit cheaper cash options unknowingly.
Similar suits target Walgreens, with plaintiff David Grabstald paying nearly double the cash price via insurance.
Affected Medications and Examples
The lawsuit spotlights generics where cash prices beat copays, including common treatments for cholesterol, blood pressure, and diabetes.
| Drug Name | Typical Cash Price (30-day) | Reported Copay (Insurance) | Savings Opportunity |
|---|---|---|---|
| Atorvastatin (generic Lipitor) | $4–$12 | $10–$50+ | Up to 80% |
| Lisinopril (blood pressure) | $4–$10 | $5–$30 | Up to 70% |
| Metformin (diabetes) | $4–$8 | $10–$40 | Up to 75% |
| Omeprazole (acid reflux) | $5–$15 | $15–$60 | Up to 75% |
Plaintiff Schultz’s case: $165 copay vs. $92 cash for a generic. CVS Health Savings Pass offers some generics for $9.95/month (uninsured), yet insured patients paid more in examples like plaintiff Odorisio’s $5 copay vs. Pass pricing.
These discrepancies span hundreds of generics, per the suit, enabled by opaque PBM contracts.
How Pharmacy Benefit Managers (PBMs) Fit In
PBMs negotiate drug prices for insurers but allegedly profit from ‘spread pricing’ and rebates. CVS owns Caremark, creating vertical integration where pharmacy and PBM arms benefit mutually.
Lawsuits claim PBMs direct higher-volume insured scripts to affiliated pharmacies like CVS, sustaining elevated copays. The FTC sued CVS Caremark, Cigna’s ESI, and OptumRx in 2024 for insulin pricing schemes inflating list prices via rebates, excluding cheaper options.
- PBMs control ~80% of U.S. prescriptions.
- Rebates totaled billions, often unpassed to patients.
- Exclusionary formularies favor high-rebate drugs.
CVS’s Defense and Broader Context
CVS denies wrongdoing: “Copays are set by insurance plans, not pharmacies. We help patients get lowest costs.” Spokesman emphasized no ‘copay clawbacks’ by Caremark.
Yet history shows issues: CVS paid $290M in 2023 for Medicare overcharges via Caremark; $17.5M in 2017 for Medicaid false claims; $37.76M for insulin over-dispensing. States like Massachusetts sued CVS for failing to report true U&C prices to Medicaid, overcharging via discount card omissions.
PBM scrutiny intensifies amid generic price crashes hurting manufacturers like Teva, while consumers see list-price-based copays.
Steps to Check If You’ve Been Overcharged
Don’t assume insurance always saves. Follow these to verify:
- Request Receipts: Get itemized CVS receipts showing cash price vs. copay.
- Compare Prices: Ask CVS pharmacist for cash/U&C price before filling.
- Use Tools: GoodRx, SingleCare compare cash vs. insurance nationwide.
- Check Explanation of Benefits (EOB): Review insurer EOB for billed amounts.
- Health Savings Pass: $9.95/month for generics (non-insured).
Pro tip: For generics < $50, cash often wins. Always ask: "What's the cash price?"
What to Do If Overcharged
Suspect overpayment? Act fast:
- Contact CVS: Pharmacist may refund/adjust if cash was cheaper.
- File Insurance Dispute: Submit cash receipt proving lower price.
- Report Fraud: State AG, FTC, or CMS if Medicare/Medicaid.
- Join Lawsuit: Monitor Schultz v. CVS for class certification.
Track records 2–3 years for tax/insurance purposes.
Tips to Save on Prescriptions Regardless
Lawsuits aside, optimize costs:
- 90-Day Supplies: Lower copays via mail-order.
- Generic Always: 80–85% cheaper.
- Discount Cards: GoodRx averages 80% off.
- Shop Chains:
- Pill Splitters: Halve 30-day costs legally.
Walmart $4 generics list.
Avoid ‘clawback’ traps: Some PBMs reclaim copays exceeding drug cost.
Frequently Asked Questions (FAQs)
Can I pay cash if insurance copay is higher?
Yes! Inform pharmacist/pharmacy to bypass insurance. Not all plans allow, but most do for generics.
Does this affect Medicare/Medicaid?
Lawsuits focus commercial insurance, but CVS settled similar govt claims.
How widespread is CVS copay overcharging?
Class-action seeks nationwide certification; similar Walgreens suit.
Will CVS refund overcharges?
Case-by-case; stronger via lawsuit/insurance dispute.
Are PBMs always bad?
Complex; FTC alleges rebate schemes inflate costs.
Stay Informed on Pharmacy Pricing Reforms
Federal probes (FTC, DOJ) target PBMs; states mandate U&C transparency. Track via FTC.gov, Congress. Patient advocacy grows—your voice matters.
Empower yourself: Question bills, compare prices, report issues. Potential settlements could yield refunds.
References
- CVS, Walgreens and PBMs worked together to gouge generic drug consumers, class action lawsuit says — Fierce Pharma. 2023-08-15. https://www.fiercepharma.com/legal/cvs-pbms-worked-together-to-gouge-generic-drug-consumers-class-action-lawsuit-says
- CVS Sued in Health Savings Pass Class Action Lawsuit — Top Class Actions. 2024-01-12. https://topclassactions.com/lawsuit-settlements/lawsuit-news/cvs-sued-in-health-savings-pass-class-action-lawsuit/
- Intervening States v. CVS Complaint — Mass.gov (official state filing). 2023-02-01. https://www.mass.gov/doc/intervening-states-v-cvs-complaint/download
- FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices — FTC.gov (official). 2024-09-17. https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices
- Judge orders CVS to pay nearly $290M for Medicare false claims — Compliance Week. 2023-07-20. https://www.complianceweek.com/regulatory-enforcement/judge-orders-cvs-to-pay-nearly-290m-for-medicare-false-claims/36172.article
- CVS Pharmacy Inc. Agrees to Pay $17.5 Million to Resolve False Prescription Billing Case — Justice.gov (official). 2017-11-07. https://www.justice.gov/archives/opa/pr/cvs-pharmacy-inc-agrees-pay-175-million-resolve-false-prescription-billing-case
- A ‘veritable playground’: CVS whistleblower details how patients were charged higher drug prices — IPM United. 2024-03-05. https://www.ipmdunited.org/post/a-veritable-playground-cvs-whistleblower-details-how-patients-were-charged-higher-drug-prices
Similar Articles
Read full bio of Sneha Tete
